A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.

MLA

Marverti, Gaetano, et al. “A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.” International Journal of Molecular Sciences, vol. 21, no. 12, June 2020, p. 4452. EBSCOhost, https://doi.org/10.3390/ijms21124452.

APA

Marverti, G., Gozzi, G., Maretti, E., Lauriola, A., Severi, L., Sacchetti, F., Losi, L., Pacifico, S., Ferrari, S., Ponterini, G., Leo, E., Costi, M. P., & D’Arca, D. (2020). A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells. International Journal of Molecular Sciences, 21(12), 4452. https://doi.org/10.3390/ijms21124452

Chicago

Marverti, Gaetano, Gaia Gozzi, Eleonora Maretti, Angela Lauriola, Leda Severi, Francesca Sacchetti, Lorena Losi, et al. 2020. “A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.” International Journal of Molecular Sciences 21 (12): 4452. doi:10.3390/ijms21124452.